OvaWatch
Commercial- Indications
- ovarian cancer
Company intelligence / Profile preview
Aspira Women's Health
Austin, Texas, United Statesaspirawh.com ↗
- Ownership
- Public · AWHL
- Employees
- ~75
- Development stage
- Commercial
01
Overview
Aspira Women’s Health has commercialized FDA-cleared blood tests—Ova1®, Overa®, and the combined Ova1Plus®—to assess the risk of ovarian malignancy in women with adnexal masses. These tests are used alongside imaging to improve clinical decision-making. The company’s new product pipeline includes a noninvasive diagnostic for endometriosis using AI-driven analysis of protein and microRNA biomarkers. Early results show high negative predictive value (>99%) for ruling out ovarian cancer with their current portfolio[1][2][7]. The company recently reached a major milestone in its ARPA-H-funded project to develop an AI-powered blood test for endometriosis diagnosis[5].
- Therapeutic areas
- OncologyWomen's Health
- Modalities
- DeviceDiagnostic test (blood-based)Artificial intelligence-powered diagnostics
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Johns Hopkins University (biomarker development)Quest Diagnostics (commercialization agreement)ARPA-H / Investor Catalyst Hub (“Cracking the Code” project funding)
Beyond the preview
Go deeper on Aspira Women's Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aspira Women's Health.